TROMBOPAG 25 7 tablets

Trombopag 25 

Trombopag 25 is a ‘platelet-stimulating drug’ that is used to treat low blood platelet counts in patients with ITP and hepatitis C virus (HCV) infections. Trombopag 25 is also used to treat people with severe aplastic anemia (SAA). Idiopathic thrombocytopenic purpura is an immunological disorder characterized by decreased platelet counts. Hepatitis C is a liver infection and inflammation brought on by the hepatitis C virus. Aplastic anemia, sometimes known as severe aplastic anemia, is a disorder in which the bone marrow fails to produce enough blood cells.

Eltrombopag, which belongs to the class of ‘thrombopoietin receptor agonists,’ is found in Trombopag 25. Thrombopoietin is a glycoprotein hormone that regulates platelet synthesis and increases the creation of megakaryocytes (large bone marrow cells). Trombopag 25 acts by raising the number of big bone marrow cells that produce platelets. As a result, Trombopag 25 aids in the growth of these bone marrow cells, boosting the production of platelets and lowering the risk of bleeding.

Follow your doctor’s instructions when taking Trombopag 25. Trombopag 25 can induce nausea, diarrhea, headache, muscle soreness, weariness, loss of appetite, fever, anemia (low blood cells), cough, and tingling numbness in certain people. These adverse effects are not experienced by everyone who takes Trombopag 25, and they differ from person to person. Please contact your doctor if you have any uncontrollable adverse effects.

Before using Trombopag 25, tell your doctor if you have had any allergic reactions to it or any other medications. Before using Trombopag 25, tell your doctor if you have any heart, kidney, or liver problems, blood disorders, blood clotting issues, or cataracts. If you are pregnant or planning to get pregnant, you should seek medical advice. Because Trombopag 25 gets into breast milk, it is not recommended for usage while nursing. Because Trombopag 25 can make you dizzy, you should only drive or use machinery when you are fully alert.

Trombopag 25’s Applications

Severe aplastic anemia, low platelet count (SAA)

Medicinal Advantages

Trombopag 25 comprises ‘Eltrombopag,’ a thrombopoietin receptor agonist used to treat low blood platelet counts in people with immunological (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections, and severe aplastic anemia (SAA). Trombopag 25 stimulates the formation of platelets by boosting megakaryocytes, which are big bone marrow cells. Platelet synthesis is stimulated by the rise in these bone marrow cells. By raising the quantity of platelets in the blood, Trombopag 25 avoids bleeding episodes.

Use Instructions

Trombopag 25 is available as an oral tablet or as an oral suspension powder. Only take Trombopag 25 if your doctor has prescribed it. The dosage will be determined by your doctor based on the severity of your medical condition. Swallow the tablet whole with a glass of water. As directed by your doctor, take Trombopag 25 on an empty stomach. It should not be crushed, chewed, or broken. Suspension powder: Combine the suspension powder with the amount of cool water specified. Take Trombopag 25 with or without food, using an oral syringe, according to the doctor’s instructions.

Storage

Store in a cool, dry location away from direct sunlight.

Trombopag 25 Side Effects

Nausea

Diarrhoea

Headache

Muscle ache

Tiredness

Appetite loss.

Fever

Anemia is a condition in which a person (lack of blood cells)

Cough

Numbness or tingling

Drug Recommendations

If you have a known allergy to Eltrombopag or other medications, please let your doctor know ahead of time. Before taking Trombopag 25, consult your doctor if you have blood clots, clotting disorders (Factor V Leiden), blood disorders such as blood cancer, myelodysplastic syndrome, cataracts, liver or renal disease. Because antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminum, selenium, and zinc), dairy products, calcium-enriched foods, and fortified juices interfere with Trombopag 25 absorption, take Eltrombopag at least two hours before or four hours after taking them. Eltrombopag is not advised to be taken during pregnancy since it may harm the fetus. If you are a breastfeeding mother, talk to your doctor before using Eltrombopag. Eltrombopag may produce dizziness and drowsiness, impairing your ability to concentrate and drive. Do not drive or operate machinery while taking it. Alcohol use should be avoided or limited when using Eltrombopag, as it may reduce the efficiency of Trombopag 25. Eltrombopag is not indicated for children under the age of one year in ITP and under the age of two in SAA.

Interactions Between Drugs

Anti-cancer medications (methotrexate, topotecan), rheumatoid arthritis drugs (ciclosporin, azathioprine), HIV/AIDS drugs (lopinavir, ritonavir), corticosteroids, and steroid hormones may interact with eltrombopag (danazol).

Eltrombopag should be taken at least two hours before or four hours after consuming dairy products, calcium-enriched meals, or fortified liquids since they interfere with Trombopag 25 absorption.

Blood clots, clotting disorders (Factor V Leiden), blood illnesses such as blood cancer, myelodysplastic syndrome, cataracts, liver or renal disease should consult a doctor before using Trombopag 25.

Safety Suggestions

ALCOHOL

To get the most out of Eltrombopag and avoid any aggravation of side effects, limit your alcohol intake while using Trombopag 25 Tablet 7’s.

PREGNANCY

Eltrombopag should not be used during pregnancy. It has the potential to affect and harm the developing infant. If you are pregnant or planning to become pregnant, please seek medical advice.

BREAST FEEDING

It’s unclear whether Eltrombopag is excreted in breast milk. If you are a nursing mother, please visit your doctor for more information before using Eltrombopag.

DRIVING

Eltrombopag can make you dizzy and weary, making it difficult to concentrate and drive. As a result, it is advised that you do not drive or use machinery until you have regained mental alertness.

LIVER

Before using Trombopag 25, tell your doctor if you have a history of liver problems. Eltrombopag has been linked to a rise in liver enzymes. Your doctor may prescribe a lower dose of Trombopag 25 to begin treatment.

KIDNEY

In cases of renal impairment, eltrombopag should be used with caution. If you have any kidney difficulties, you should seek medical counsel before commencing Eltrombopag.

No habit formation

Advice on Diet and Lifestyle

Reduce your intake of fatty and sodium-rich processed foods by eating more natural and healthful foods.

Maintaining excellent health requires frequent exercise.

Avoid smoking and consuming alcoholic beverages.

To reduce the risk of bleeding, avoid activities such as contact sports and utilize sharp objects such as nail cutters and razors.

Lean meat, chicken, crab, turkey, cattle, and fish are high in protein and can help improve platelet count.

The greatest natural therapy for increasing platelet count is to eat papaya; you can also use a blend of papaya leaves.

Pomegranate, beetroot, green leafy vegetables, carrots, raisins, oranges, peanuts, kidney beans, and black-eyed peas are all iron-rich foods to include in your diet.

Guava, black currant, red pepper, kiwi, green peppers, orange, strawberries, pineapple, peas, mango, grapefruit, and broccoli are all good sources of vitamin C.

Recommendations

Keep track of your blood pressure and blood sugar levels on a daily basis, and get medical advice if you detect any changes.

Because Eltrombopag affects liver enzymes, your doctor may recommend liver function tests to assess your aspartate aminotransferase (AST), alanine aminotransferase (ALT), and bilirubin levels before you start therapy and every two weeks after you finish.

Because eltrombopag may interfere with creatinine and bilirubin lab tests, please notify your doctor and laboratory personnel ahead of time.

Additional Information: This item is non-refundable.

Glossary of Diseases and Conditions

Immune thrombocytopenic purpura (ITP) is a type of thrombocytopenic purpura that is caused by an unknown cause. It’s an immunological disorder characterized by low platelet counts and abnormal blood clotting. It happens when the immune system assaults its own platelets by mistake. Children can get ITP, which is followed by a viral infection. Easy bruising, bleeding from the gums and nose, blood in the urine and stools, strong menstrual flow, and pinpoint-sized reddish-purple patches on the lower thighs are all symptoms of ITP.

Hepatitis C is a liver infection and inflammation brought on by the hepatitis C virus. Acute and chronic hepatitis can both be caused by this virus. Acute hepatitis C is a relatively short-term infection that can last up to six months. Chronic hepatitis C is a long-term infection that can develop to additional serious liver issues such as cancer or cirrhosis (inflammation of the liver). Fatigue, nausea, loss of appetite, and yellowing of the eyes and skin are all symptoms of hepatitis C.

Aplastic anemia, commonly known as bone marrow aplasia, is a kind of anemia. It’s a disorder in which the bone marrow fails to produce enough blood cells. Damage to the bone marrow is a typical cause of SAA. Radiation, chemotherapy, toxic chemicals, certain medicines, and infections can cause this damage, which can be congenital or caused by radiation, chemotherapy, toxic chemicals, and infections. Fatigue, frequent infections, a fast heart rate, and bleeding are all symptoms of SAA.

FAQs

Eltrombopag is a supplement that comprises Eltrombopag, a substance that increases platelet synthesis (which aids in clotting) in megakaryocytes (bone marrow cells). In disorders like immunological (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections, and severe aplastic anemia, Eltrombopag reduces the likelihood of bleeding episodes (SAA).

Even if you feel better, keep taking Eltrombopag. To avoid recurrence of symptoms and aggravation of the disease, it should be used exactly as prescribed by your doctor.

In situations of allergic reactions, blood clots, clotting disorders (Factor V Leiden), blood disorders such as blood cancer, myelodysplastic syndrome, cataracts, liver or renal ailments, eltrombopag should be taken with caution and only under the supervision of a specialist.

Eltrombopag reduces the risk of bleeding by increasing the number of platelets in your blood. However, you should avoid activities that raise your risk of bleeding, such as contact sports and the use of sharp devices such as razors and nail cutters.

Eltrombopag should be taken on an empty stomach. Because antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminum, selenium, and zinc), dairy products, calcium-enriched foods, and fortified juices interfere with Trombopag 25 absorption, take Eltrombopag at least two hours before or four hours after taking them.